# edaravone

NDC: 39822-4510
Generic name: edaravone
Labeler / Manufacturer: XGen Pharmaceuticals DJB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20241202

FDA application: ANDA217565

## Active ingredients

- EDARAVONE: 60 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"39822-4510"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=39822-4510
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8245a98-2ccb-4062-b865-3aa348351b48